TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT study. Unique sublingual formulation designed for bedtime dosing bypa ...
Neurologists participating in the survey also reported growing dissatisfaction with available treatment options as Parkinson’s disease progresses. Physicians estimated that approximately 45% of their ...
About VIVUS VIVUS is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical ...
Participants in the combined treatment group lost significantly more weight at 3, 6, and 12 months and were more likely to lose 5%, 10%, or >15% of their body weight at 12 months compared with DELI al ...
INGREZZA showed a nearly two-fold higher VMAT2 occupancy, consistent with greater potency when compared to AUSTEDO XR (deutetrabenazine) after a single ...
January is exciting and exhausting because we chase newness and ignore maintenance. To succeed, we need to reinforce systems, ...
PsyPost on MSN
Scientists reveal atypical depression is a distinct biological subtype linked to antidepressant resistance
A new genetic and clinical analysis suggests that atypical depression represents a distinct biological subtype of the ...
Three dietary supplements were recalled across the United States last week due to undeclared ingredients that could raise serious health concerns.
Explore 2025 managed care enforcement trends under the Trump administration. Learn about Department of Justice (DOJ) and ...
A reminder about influenza (or the flu): its symptoms include, but are not limited to fever, headache, cough, sore throat, muscle aches, loss of appetite, nausea, vomiting, diarrhea (more common in ...
The most common side effects of JORNAY PM in clinical studies in children ages 6 to 12 with ADHD include trouble sleeping, nausea, decreased appetite, restlessness (psychomotor hyperactivity), ...
DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results